The prognostic value of biological markers in paediatric Hodgkin lymphoma
- 26 November 2015
- journal article
- research article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 52, 33-40
- https://doi.org/10.1016/j.ejca.2015.09.003
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Circulating myeloid‐derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up‐front with a risk‐adapted strategyBritish Journal of Haematology, 2014
- Treatment of Children and Adolescents With Hodgkin Lymphoma Without Radiotherapy for Patients in Complete Remission After Chemotherapy: Final Results of the Multinational Trial GPOH-HD95Journal of Clinical Oncology, 2013
- Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trialBlood, 2012
- CD68 and CD163 as prognostic factors for Korean patients with Hodgkin lymphomaEuropean Journal of Haematology, 2011
- Early Interim 2-[18F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: A Report From a Joint Italian-Danish StudyJournal of Clinical Oncology, 2007
- Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphomaBlood, 2006
- Long-Term Cause-Specific Mortality of Patients Treated for Hodgkin’s DiseaseJournal of Clinical Oncology, 2003
- A Prognostic Score for Advanced Hodgkin's DiseaseNew England Journal of Medicine, 1998
- The balance between cure and late effects in childhood Hodgkin's lymphoma: The experience of the German-Austrian Study-Group since 1978Annals Of Oncology, 1996
- Late Effects of Treatment for Childhood Hodgkin's DiseaseNew England Journal of Medicine, 1996